- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05777343
Exercise, PNE and Cognitive Training in Individuals With Chronic Low Back Pain
Pain Neuroscience Education, Exercise, and Cognitive Training in Individuals With Idiopathic Chronic Low Back Pain: a Three-arm Randomized Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study aims of to investigate whether combining cognitive training to exercise and Pain Neuroscience Education (PNE) will contribute to reduction of pain and associated symptoms (i.e., catastrophizing, fear of movement, disability) in individuals with low back pain (LBP).
It will have three arms of which will receive exercise, PNE and/or cognitive training for 8 weeks (Group I - exercise and PNE; Group II - exercise, PNE and cognitive training; Group III - cognitive training).
Participants will be assessed for pain characteristics, psychological, and cognitive aspects at baseline, post-intervention and at 3 months follow-up.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ellen P. Nery, Ms.
- Phone Number: +351234370200
- Email: ellen.nery@ua.pt
Study Contact Backup
- Name: Anabela Silva
- Phone Number: +351234370200
- Email: asilva@ua.pt
Study Locations
-
-
-
Aveiro, Portugal
- Recruiting
- University of Aveiro
-
Contact:
- Ellen Nery
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- have chronic idiopathic LBP
- report pain intensity of at least 2 out of 10 on the Numeric Pain Rating Scale
- 18 to 64 years old
- Be able to read, write and speak Portuguese
- Asses to personal computer and internet for those receiving cognitive training
Exclusion Criteria:
- individuals receiving any chronic treatment for their pain
- symptoms of peripheral nervous system pathology (e.g., motor weakness and sensory disturbance);
- a diagnosis of an ongoing neurological disease with peripheral or central nervous system involvement or relevant sequela;
- having a diagnosis of ongoing psychiatric disease
- having relevant cognitive impairment as assessed by Montreal Cognitive Assessment (MoCA).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention 1
Participants will receive exercise, PNE and online cognitive training sessions.
|
Cognitive training combined with the recommended non-pharmacological intervention (Exercise and Pain Neuroscience Education).
|
|
Active Comparator: Intervention 2
Participants will receive exercise and pain neuroscience education (PNE).
|
Recommended non-pharmacological intervention (Exercise and Pain Neuroscience Education).
|
|
Active Comparator: Intervention 3
Participants will receive online cognitive training sessions.
|
Online sessions of cognitive training.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Numeric Pain Rating Scale Numeric Pain Rating Scale
Time Frame: baseline
|
Measured with a 11-point scale ranging from 0 meaning "no pain" to 10 meaning "the worst pain imaginable".
|
baseline
|
|
Numeric Pain Rating Scale Numeric Pain Rating Scale
Time Frame: post-intervention - 8 weeks
|
Measured with a 11-point scale ranging from 0 meaning "no pain" to 10 meaning "the worst pain imaginable".
|
post-intervention - 8 weeks
|
|
Numeric Pain Rating Scale Numeric Pain Rating Scale
Time Frame: 3 months follow-up
|
Measured with a 11-point scale ranging from 0 meaning "no pain" to 10 meaning "the worst pain imaginable".
|
3 months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cognitive Function
Time Frame: baseline
|
Cognitive function will be assessed using the Brain on Track® (BoT), a self-administered computerized test that evaluates different cognitive domains.
Each test has a virtually unlimited range score and considers the maximum number of correct answers that a person gives in a fixed period of time and higher scores represent higher cognitive performance.
|
baseline
|
|
Cognitive Function
Time Frame: post-intervention - 8 weeks
|
Cognitive function will be assessed using the Brain on Track® (BoT), a self-administered computerized test that evaluates different cognitive domains.
Each test has a virtually unlimited range score and considers the maximum number of correct answers that a person gives in a fixed period of time and higher scores represent higher cognitive performance.
|
post-intervention - 8 weeks
|
|
Cognitive Function
Time Frame: 3 months follow-up.
|
Cognitive function will be assessed using the Brain on Track® (BoT), a self-administered computerized test that evaluates different cognitive domains.
Each test has a virtually unlimited range score and considers the maximum number of correct answers that a person gives in a fixed period of time and higher scores represent higher cognitive performance.
|
3 months follow-up.
|
|
Roland Morris disability questionnaire
Time Frame: baseline
|
The Roland Morris assesses disability caused by LBP.
It has 24 statements, and the individual must tick those that relate to him that day.
The total score ranges from "0" meaning no disability to "24" meaning maximum disability.
|
baseline
|
|
Roland Morris disability questionnaire
Time Frame: post-intervention - 8 weeks
|
The Roland Morris assesses disability caused by LBP.
It has 24 statements, and the individual must tick those that relate to him that day.
The total score ranges from "0" meaning no disability to "24" meaning maximum disability.
|
post-intervention - 8 weeks
|
|
Roland Morris disability questionnaire
Time Frame: 3 months follow-up
|
The Roland Morris assesses disability caused by LBP.
It has 24 statements, and the individual must tick those that relate to him that day.
The total score ranges from "0" meaning no disability to "24" meaning maximum disability.
|
3 months follow-up
|
|
Central sensitization Inventory
Time Frame: baseline
|
The central sensitization inventory (CSI) assesses symptoms of central sensitization.
The total score ranges from 0 to 100 points and to identify central sensitization in individuals, the recommended cut-off score is 40 points.
|
baseline
|
|
Central sensitization Inventory
Time Frame: post-intervention - 8 weeks
|
The central sensitization inventory (CSI) assesses symptoms of central sensitization.
The total score ranges from 0 to 100 points and to identify central sensitization in individuals, the recommended cut-off score is 40 points.
|
post-intervention - 8 weeks
|
|
Central sensitization Inventory
Time Frame: 3 months follow-up
|
The central sensitization inventory (CSI)assesses symptoms of central sensitization.
The total score ranges from 0 to 100 points and to identify central sensitization in individuals, the recommended cut-off score is 40 points.
|
3 months follow-up
|
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: baseline
|
HADS evaluates symptoms of anxiety and depression.
The total scores range from 0 to 21 points with a 4-point Likert scale rating between "most of the times" and "not at all" with higher scores indicating higher levels of anxiety and depression.
|
baseline
|
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: post-intervention - 8 weeks
|
HADS evaluates symptoms of anxiety and depression.
The total scores range from 0 to 21 points with a 4-point Likert scale rating between "most of the times" and "not at all" with higher scores indicating higher levels of anxiety and depression.
|
post-intervention - 8 weeks
|
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 3 months follow-up.
|
HADS evaluates symptoms of anxiety and depression.
The total scores range from 0 to 21 points with a 4-point Likert scale rating between "most of the times" and "not at all" with higher scores indicating higher levels of anxiety and depression.
|
3 months follow-up.
|
|
TAMPA Scale of Kinesiophobia
Time Frame: baseline
|
The Tampa scale measures the fear of movement related to chronic LBP.
The short version has 13 items in a 4-point Likert scale rating between "strongly disagree" and "strongly agree".
The total scores range from 0 to 52 points with higher levels indicating higher fear of movement.
|
baseline
|
|
TAMPA Scale of Kinesiophobia
Time Frame: post-intervention - 8 weeks
|
The Tampa scale measures the fear of movement related to chronic LBP.
The short version has 13 items in a 4-point Likert scale rating between "strongly disagree" and "strongly agree".
The total scores range from 0 to 52 points with higher levels indicating higher fear of movement.
|
post-intervention - 8 weeks
|
|
TAMPA Scale of Kinesiophobia
Time Frame: 3 months follow-up.
|
The Tampa scale measures the fear of movement related to chronic LBP.
The short version has 13 items in a 4-point Likert scale rating between "strongly disagree" and "strongly agree".
The total scores range from 0 to 52 points with higher levels indicating higher fear of movement.
|
3 months follow-up.
|
|
Pain Catastrophizing Scale
Time Frame: Baseline
|
The Pain Catastrophizing Scale (PCS) assess catastrophic thinking related to pain.
It has 13 statements on a 5-point scale ranging from 0 meaning "not at all" and 4 meaning "all the time".
The total score ranges from 0 to 52 with higher scores indicating higher levels of catastrophizing.
|
Baseline
|
|
Pain Catastrophizing Scale
Time Frame: post-intervention - 8 weeks
|
The Pain Catastrophizing Scale (PCS) assess catastrophic thinking related to pain.
It has 13 statements on a 5-point scale ranging from 0 meaning "not at all" and 4 meaning "all the time".
The total score ranges from 0 to 52 with higher scores indicating higher levels of catastrophizing.
|
post-intervention - 8 weeks
|
|
Pain Catastrophizing Scale
Time Frame: 3 months follow-up.
|
The Pain Catastrophizing Scale (PCS) assess catastrophic thinking related to pain.
It has 13 statements on a 5-point scale ranging from 0 meaning "not at all" and 4 meaning "all the time".
The total score ranges from 0 to 52 with higher scores indicating higher levels of catastrophizing.
|
3 months follow-up.
|
|
Basic Scale on Insomnia Complaints and Quality of Sleep (BaSIQs)
Time Frame: baseline
|
The scale assess the difficulties with sleep onset and maintenance and the quality and depth of sleep during the last month and considering a normal week.
Total score ranges from 0 to 28 points and higher scores are associated with poor quality of sleep.
|
baseline
|
|
Basic Scale on Insomnia Complaints and Quality of Sleep (BaSIQs)
Time Frame: post-intervention - 8 weeks
|
The scale assess the difficulties with sleep onset and maintenance and the quality and depth of sleep during the last month and considering a normal week.
Total score ranges from 0 to 28 points and higher scores are associated with poor quality of sleep.
|
post-intervention - 8 weeks
|
|
Basic Scale on Insomnia Complaints and Quality of Sleep (BaSIQs)
Time Frame: 3 months follow-up.
|
The scale assess the difficulties with sleep onset and maintenance and the quality and depth of sleep during the last month and considering a normal week.
Total score ranges from 0 to 28 points and higher scores are associated with poor quality of sleep.
|
3 months follow-up.
|
|
Two-point discrimination
Time Frame: baseline
|
Two-point discrimination is used to assess cortical reorganization.
|
baseline
|
|
Two-point discrimination
Time Frame: post-intervention - 8 weeks
|
Two-point discrimination is used to assess cortical reorganization.
|
post-intervention - 8 weeks
|
|
Two-point discrimination
Time Frame: 3 months follow-up
|
Two-point discrimination is used to assess cortical reorganization.
|
3 months follow-up
|
|
Patient's Global Impression of Change (PGIC)
Time Frame: post-intervention - 8 weeks
|
PGIC evaluates the perception of improvement associated with the intervention.
Participants are instructed to select on a scale from 1 ("No change or condition worsened") to 7 ("Much better, and with a considerable improvement that made all the difference") the statement that best reflected the impact of the intervention on their condition.
|
post-intervention - 8 weeks
|
|
Patient's Global Impression of Change (PGIC)
Time Frame: 3 months follow-up.
|
PGIC evaluates the perception of improvement associated with the intervention.
Participants are instructed to select on a scale from 1 ("No change or condition worsened") to 7 ("Much better, and with a considerable improvement that made all the difference") the statement that best reflected the impact of the intervention on their condition.
|
3 months follow-up.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Anabela Silva, PhD, School of Health Sciences, University of Aveiro
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RCTCognitiveTraining
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.